Ascension Michigan

Genetesis Announces Formal Publication of Results from the MAGNETO Trial

Retrieved on: 
星期二, 四月 2, 2024
Health, Other Health, General Health, Clinical Trials, Research, Science, Cardiology, Radiation, Ascension Michigan, Dipyridamole, Moyamoya disease, Risk, Patient, Emergency medicine, Guideline, Ischemia, MD, Publication, FACEP, ED, Medical director, MCG, Medical device

Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice .

Key Points: 
  • Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that official results from its MAGNETO trial were published in a special issue of the American Heart Journal Plus: Cardiology Research and Practice .
  • The results of MAGNETO demonstrate MCG’s ability to identify myocardial ischemia in low-to-intermediate risk patients presenting to the emergency department (ED) with acute chest pain and validate MCG’s performance compared to tests that comprise the current standard of care.
  • “To the extent of my awareness, this constitutes the most extensive MCG trial conducted in the past 60 years, dating back to the inception of MCG research.
  • Additional analyses of data collected in the MAGNETO trial are also planned for publication in the same special issue where topline results have just been published.

Karmanos welcomes new VP of the Karmanos Cancer Network

Retrieved on: 
星期二, 十二月 5, 2023
Proton, Nursing, Detroit Medical Center, Genetic counseling, RN, McLaren, Central Michigan University, DMC, Karmanos Cancer Institute, Michigan State University, Patient, MSA, Ascension Michigan, University of Michigan, Community engagement, McLaren Flint, Oncology, Clinical trial, Physician, Business, Certification, Science, Network, McLaren Health Care Corporation, Karmanos

DETROIT, Dec. 5, 2023 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute has appointed Doris Ranski-Zazula, RN, MSA, as the vice president of the Karmanos Cancer Network, part of McLaren Health Care. The Karmanos Cancer Network is one of the largest cancer care and research networks in the United States, with 15 locations anchored by the Karmanos Cancer Institute freestanding cancer hospital headquartered in Detroit.   

Key Points: 
  • DETROIT, Dec. 5, 2023 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute has appointed Doris Ranski-Zazula, RN, MSA, as the vice president of the Karmanos Cancer Network , part of McLaren Health Care.
  • The Karmanos Cancer Network is one of the largest cancer care and research networks in the United States, with 15 locations anchored by the Karmanos Cancer Institute freestanding cancer hospital headquartered in Detroit.
  • Ranski-Zazula transitioned to this position, having been the regional director of Cancer Services for Karmanos locations in Flint, Pontiac and Lapeer.
  • Ranski-Zazula will report to Brian Gamble, president of the Karmanos Cancer Hospital and Network.

Henry Ford Health and Ascension Michigan Announce Agreement to Dramatically Expand and Enhance Integrated Healthcare Services Across Southeast and Mid-Michigan

Retrieved on: 
星期三, 十月 18, 2023
Ascension St. Mary's Hospital, Genesys, Health, Hope, Physician, Henry Ford Health, Catholic Church, Organization, Population health, Research, Senior, Ascension, Partnership, Safety, Investment, Ascension Providence Hospital, Novi Campus, Patient, Nursing, Hospital, Management, Ascension Michigan

Detroit, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Henry Ford Health and Ascension Michigan have signed an agreement to enter a joint venture that will bring together Ascension’s southeast Michigan and Genesys healthcare facilities and assets with Henry Ford’s.

Key Points: 
  • Detroit, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Henry Ford Health and Ascension Michigan have signed an agreement to enter a joint venture that will bring together Ascension’s southeast Michigan and Genesys healthcare facilities and assets with Henry Ford’s.
  • Ascension Michigan’s acute care hospitals that are included in the partnership are: Ascension Genesys Hospital; Ascension Macomb-Oakland Hospital, Warren and Madison Heights Campuses; Ascension Providence Hospital, Novi and Southfield Campuses; Ascension Providence Rochester Hospital; Ascension River District Hospital; and Ascension St. John Hospital.
  • All of Henry Ford’s acute care hospitals and other care facilities and assets, including Health Alliance Plan, will be included in the partnership.
  • Ascension Michigan’s southwest and northern hospitals—Ascension Borgess Hospital, Ascension Borgess Allegan Hospital; Ascension Borgess-Lee Hospital, Ascension Borgess-Pipp Hospital; Ascension St. Joseph Hospital, Ascension St. Mary’s Hospital and Ascension Standish Hospital—will remain valued members of Ascension’s national health ministry and continue to provide their communities with high-quality Catholic healthcare.

Henry Ford Health and Ascension Michigan Announce Agreement to Dramatically Expand and Enhance Integrated Healthcare Services Across Southeast and Mid-Michigan

Retrieved on: 
星期三, 十月 18, 2023
Ascension St. Mary's Hospital, Genesys, Health, Hope, Physician, Henry Ford Health, Catholic Church, Organization, Population health, Research, Senior, Ascension, Partnership, Safety, Investment, Ascension Providence Hospital, Novi Campus, Patient, Nursing, Hospital, Management, Ascension Michigan

Detroit, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Henry Ford Health and Ascension Michigan have signed an agreement to enter a joint venture that will bring together Ascension’s southeast Michigan and Genesys healthcare facilities and assets with Henry Ford’s.

Key Points: 
  • Detroit, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Henry Ford Health and Ascension Michigan have signed an agreement to enter a joint venture that will bring together Ascension’s southeast Michigan and Genesys healthcare facilities and assets with Henry Ford’s.
  • Ascension Michigan’s acute care hospitals that are included in the partnership are: Ascension Genesys Hospital; Ascension Macomb-Oakland Hospital, Warren and Madison Heights Campuses; Ascension Providence Hospital, Novi and Southfield Campuses; Ascension Providence Rochester Hospital; Ascension River District Hospital; and Ascension St. John Hospital.
  • Ascension Michigan’s southwest and northern hospitals—Ascension Borgess Hospital, Ascension Borgess Allegan Hospital; Ascension Borgess-Lee Hospital, Ascension Borgess-Pipp Hospital; Ascension St. Joseph Hospital, Ascension St. Mary’s Hospital and Ascension Standish Hospital—will remain valued members of Ascension’s national health ministry and continue to provide their communities with high-quality Catholic healthcare.
  • Both organizations are committed to working to maintain the Catholic identity of the Ascension Michigan facilities included in the partnership.

The Inner Circle Acknowledges, Gary L. Berg as a Most Trusted Healthcare Professional for his contributions to the field of Pulmonology

Retrieved on: 
星期一, 四月 24, 2023
Bachelor, DOS, Des Moines University, Osteopathic medicine in the United States, Internal medicine, Ascension Michigan, Public, AOBIM, Respiratory system, Attention, American Osteopathic Association, AOA, Inner circle, American Osteopathic Board of Internal Medicine, Organization, Public health, Physician, Michigan State University, Doctor of Osteopathic Medicine, Hospital, Patient, Sleep, Ascension, Disease, Nursing, Dentistry, Microbiology, Pulmonology

BLOOMFIELD HILLS, Mich., April 24, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Gary L. Berg is acknowledged as a Most Trusted Healthcare Professional for his contributions to the field of Pulmonology.

Key Points: 
  • BLOOMFIELD HILLS, Mich., April 24, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Gary L. Berg is acknowledged as a Most Trusted Healthcare Professional for his contributions to the field of Pulmonology.
  • He completed an internship and residency at Ascension Macomb-Oakland Hospital and is board-certified in pulmonary disease and internal medicine by the American Osteopathic Board of Internal Medicine (AOBIM).
  • According to Dr. Berg, pulmonology is a medical specialty that deals with diseases involving the respiratory tract.
  • The doctor has been married to Mrs. Carolyn Berg for 30 years and they have one daughter, Elizabeth.

First Came Robotic Surgery. Then Artificial Intelligence. Now Leading Detroit-Area Physician Reveals a "Balancing Act" for Knee Replacement

Retrieved on: 
星期二, 三月 7, 2023
Motion, American Academy, Physician, Friends, Journal, Research, AAOS, Elective surgery, Intelligence, Ascension Michigan, Swimming, Patient, Risk, Abdominal musculature absent with microphthalmia and joint laxity, Arthralgia, Robotics, Orthopedic surgery, Annual general meeting, Artificial intelligence, Ascension Providence Hospital, Novi Campus, MI, Pain, 3D, Anatomy, Patient satisfaction, Dentistry, Arthroplasty

LAS VEGAS, March 7, 2023 /PRNewswire/ -- Jeffrey DeClaire, M.D., a pioneer in robotic-assisted total knee replacement and founder of the Michigan Knee Institute, is the first in the world to use a new balancing tool that combines artificial intelligence and robotic-assisted technology, provides superior outcomes for knee replacement patients. 

Key Points: 
  • , a pioneer in robotic-assisted total knee replacement and founder of the Michigan Knee Institute , is the first in the world to use a new balancing tool that combines artificial intelligence and robotic-assisted technology, provides superior outcomes for knee replacement patients.
  • He participated in clinical studies of the BalanceBot™, a robotic knee ligament tensioning device that helps the surgeon balance knee ligaments and craft an accurate surgical plan.
  • The BalanceBo t™, manufactured by Corin Group, allows physicians to have a "second pair of eyes" before they make the cuts.
  • To learn more about Dr. DeClaire and the Elite Knee procedure, visit michigankneeinstitute.com or call 248-609-9111.

CathWorks Announces Key Events for ACC 2023

Retrieved on: 
星期四, 三月 2, 2023
UC, Coronary artery disease, Rabin Medical Center, Medtronic, Treatment, Cardiac catheterization, Patient, Ascension St. Mary's Hospital, ACC, UC San Diego Health, Ernest, Faculty, FFR, Ascension Michigan, Partnership, American College, Physician, Pharmaceutical industry, Diagnosis

KFAR-SABA, Israel & IRVINE, Calif., March 2, 2023 /PRNewswire/ -- CathWorks announced today key events for the company during the annual American College of Cardiology (ACC) 2023 conference taking place March 4 to 6 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.

Key Points: 
  • KFAR-SABA, Israel & IRVINE, Calif., March 2, 2023 /PRNewswire/ -- CathWorks announced today key events for the company during the annual American College of Cardiology (ACC) 2023 conference taking place March 4 to 6 at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
  • The CathWorks FFRangio® System, which provides a drug-free and wire-free intraprocedural physiological assessment for the entire coronary tree, will be featured prominently during ACC.
  • These long-term FFRangio outcomes data should prove reassuring to centers who have recently adopted or are considering adopting CathWorks angio-based technology," stated Professor Kornowski.
  • Attendees can register for our joint symposia or sign up for a Meet the Expert session at ACC 2023 through the following link: https://ww2.cath.works/acc2023-mdt .

Genetesis Announces New Appointments to Executive Leadership Team

Retrieved on: 
星期五, 一月 20, 2023
Venture Capital, Cardiology, Radiology, Biotechnology, Health, FDA, Medical Devices, Professional Services, Ecosystem, MCG, Emergency medicine, Medical director, Ascension Michigan, Cardiac catheterization, Publication, Yale Physician Associate Program, Ascension St. Mary's Hospital, De novo, Medical Affairs Bureau, Medicare, Magnetocardiography, Diagnosis, Patient, Market access, Research, Abbott Laboratories, Dipyridamole, Physician, Pain, Management, Medical device

Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced the appointment of three new members to the executive leadership team who will oversee and execute key aspects of commercialization and clinical research for its flagship solution, CardioFlux.

Key Points: 
  • Genetesis, Inc., the leader in biomagnetic cardiac imaging solutions, today announced the appointment of three new members to the executive leadership team who will oversee and execute key aspects of commercialization and clinical research for its flagship solution, CardioFlux.
  • This announcement comes in anticipation of market authorization from the FDA, which Genetesis expects to see later this year.
  • “As we inch ever closer to the FDA granting our De Novo request, expanding our team to cover new disciplines and encompass additional experience has become critical,” said Peeyush Shrivastava, co-founder and CEO of Genetesis.
  • Joining this team as we bring the promise of MCG to patients and physicians alike feels like a natural extension of the path I’ve taken thus far.”

FDA Approves Impella ECP Pivotal Heart Pump and First Patients Enrolled in Pivotal Clinical Trial

Retrieved on: 
星期三, 十二月 21, 2022
Medical Devices, Health, Clinical Trials, Pharmaceutical, Cardiology, Biotechnology, Degenerative disease, MD, ECP, Multimedia, PCI, Patient, Ascension St. Mary's Hospital, Ascension Michigan, Physician, ABMD, FDA, EFS, Impella, Patient safety, Pharmaceutical industry, Medical device, Abiomed

Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial.

Key Points: 
  • Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial.
  • (Graphic: Business Wire)
    Impella ECP is the world’s smallest heart pump and the only heart pump compatible with small bore access and closure techniques.
  • Both patients enrolled in the trial received Impella ECP support during challenging left main coronary bifurcation stent procedures involving heavily calcified lesions.
  • The Impella ECP Pivotal Clinical Trial received FDA approval on March 2, 2022 and will enroll up to 217 patients in the U.S. Additional details about the pivotal trial are available here .

Hart Medical Equipment Names New Vice President of Operations

Retrieved on: 
星期二, 十二月 6, 2022
Ascension Michigan, Bellevue Hospital, McLaren Health Care Corporation, Hart, Health, Patient, Blanchard Valley Health System, DME, Associate

GRAND BLANC, Mich., Dec. 6, 2022 /PRNewswire/ -- On December 5, 2022, Matt Wagenhauser was named Vice President of Operations of Hart Medical Equipment, with 23 locations in Michigan and Ohio, and serving patients nationwide via their ecommerce platform.

Key Points: 
  • GRAND BLANC, Mich., Dec. 6, 2022 /PRNewswire/ -- On December 5, 2022, Matt Wagenhauser was named Vice President of Operations of Hart Medical Equipment, with 23 locations in Michigan and Ohio, and serving patients nationwide via their ecommerce platform.
  • Matt, a veteran of both the healthcare and DME industries, with over two decades of healthcare management and business development, joined Hart from his latest role as Associate Vice President with ProMedica Physician Group in Toledo, Ohio.
  • Matt, an Ohio native, has deep ties to the community and extensive business relations; his office will be headquartered in Ohio.
  • Hart has shared ownership by Henry Ford Health, McLaren Health Care, Ascension Genesys Hospital, Blanchard Valley Health System, Wood County Hospital, and The Bellevue Hospital.